FOXO3 and prostate carcinoma: Akt/mTOR pathway is known to repress BH3-only proteins through the FoxO3A transcription factor phosphorylation39–41 and Naftopidil was described to inhibit Akt phosphorylation in gastric and prostate cancer cells32,34,42.